Wealth Enhancement Trust Services’s Ocular Therapeutix OCUL Stock Holding History

Wealth Enhancement Trust Services’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79	Buy	+8	New	+$73	﹤0.01%	1430

Other funds holding OCUL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ELI

Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Wealth Enhancement Trust Services's OCUL Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 8 shares worth $79. The stake represents ﹤0.01% of the portfolio and ranks #1430 among its holdings.

133 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Wealth Enhancement Trust Services held 8 shares of Ocular Therapeutix worth $79 as of Q2 2026.
Ocular Therapeutix was a new Wealth Enhancement Trust Services position in Q2 2026.
Ocular Therapeutix made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1430 holding.
133 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.